Program

Here you can download the program as PDF.

WEDNESDAY, DECEMBER 10, 2025

7:30 - 10:00 PM | Social event + Dinner

THURSDAY, DECEMBER 11, 2025

8:30 - 10:00 AM | Plenary Session 1: New insights into vacular biology
Chairs: Jes-Niels Böckel / Ulrike Schatz

• Molecular drivers of atherosclerosis
  Christoph Binder 
• Novel regulators of endothelial function
  Hellmut Augustin
  
• Cardiovascular changes driven by kidney disease
  Ralph Brandes

Scientific Session 1: New insights into lipoprotein function and lipid signalling
Chairs: Heribert Schunkert / Ingo Hilgendorf

• Effects of physical exercise on RNAs in cardiovascular diseases
  Xiao Junjie
• Epigenetic effects of ACLY inhibition / Bempedoic acid
  Bilal Sheikh
• Genetics of lipoprotein mediated atherogenecity
  Jan Boren

Scientific Session 2: Oxlipins - facts and myths
Chairs: Daniel Huster / Trian Chavakis

• Oxylipins in neuroinflammation
  Uta Ceglarek
• Oxylipins: from detection to function
  Nils Helge Schebb
• Interactions between lipid and adipocyte metabolism
  Jörg Heeren

Scientific Session 3: Mechanisms of atherogenesis
Chairs: Daniel Sedding / Ulf Landmesser

• Presentation from selected abstracts
• Cardiovascular changes driven by kidney disease
  Rafael Kramann
• Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming
  Hafid Ait-Oufella
• ADAMTS and atherosclerosis
  Thorsten Kessler
  

Scientific Session 4: Membrane lipids and signaling
Chairs: Claudia Stäubert / Georg Künze

• Presentation from selected abstracts
• Modulation of GPCR signaling by plasma lipids
  Alejandra Tomas Catala
• Membrane-Mediated Allosteric Action of Serotonin on a Noncognate G-Protein-Coupled Receptor
  Daniel Huster
  
• SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor
  Stefan Offermanns

2:30 - 4:00 PM AM | Plenary Session 2: New insights into pathogenesis of CVD
Chairs: Ulrich Laufs / Matthias Blüher

• Remnant cholesterol and atherosclerosis
  Borge Nordestgaard
• Clonal Hematopoesis of Indeterminate Potential
  Peter Libby

Scientific Session 5: Sex-differences in cardio-metabolic disease
Chairs: Alexander Bartelt / Arnold von Eckardstein

• Influence of sex and gender on the biology of atheresclerosis
  Katariina Öörni
• Atheroprotection by Cannabinoid receptor deletion in sex-specific manner
  Sabine Steffens
• Data on high-risk subgroups from large clinical trials Johan
  Wouter Jukema

Scientific Session 6: Epigenetic aspects of cardiometabolic diseases
Chairs: Peter Kovacs / Maria Keller

• Effects of nutrition on obesogenic epigentic marks
  Iris Shai
• Epigenetics link obesity to cardiometabolic diseases
  Camilla Scheele
• Dysregulation of DNA methylation by the environment
  Sören Nielsen
  

FRIDAY, DECEMBER 12, 2025

Scientific Session 7: Mechanisms of obesity: updates from the clinic
Chairs: Ioanna Gouni-Berthold / Kathrin Landgraf

• Presentation from selected abstracts
• How does adipose tissue dysfunction cause cardiometabolic diseases
  Assaf Rudich
• Adipose tissue mitochondria in obesity and weight loss – insights from twin cohorts and intervention studies
  Kirsi H Pietiläinen
• Learning from the extremes: Constitutional Thinness
  Zach Gerhart-Hines

Scientific Session 8: Priming of cardiovascular disease early in life
Chairs: Ana Zenclussen / Sandra Blois

• Presentation from selected abstracts
• Maternal polycystic ovary syndrome and Offspring's Risk of Cardiovascular diseases
  Krisztina László
• Priming of obesity in offspring by sperm properties
  Rafaelle Teperino
• Priming of vascular disease during early-life
  Amanda Sferruzzi-Perri

Scientific Session 9: Insigths into new approaches to lipid lowering
Chairs: Uta Ceglarek / Ralph Burkhardt

• Presentation from selected abstracts
• New lipid drugs in clinical development
  Ulrich Laufs
  
• Challenges and opportunities in Lp(a) analysis
  Matthias Nauck
• Health economics of lipid lowering therapies
  Winfried März

Scientific Session 10: From big data to diagnostics in lipid disorders and related diseases
Chairs: Markus Scholz / Kristin Reiche

• Presentation from selected abstracts
• Lipidomics in circulating vascular cells driving clotting
  Valerie O‘Donnell
• Multi-omics in acute and chronic coronary syndrome
  Leo Nicolai
• Mitochondrial omics
  Leif S. Ludwig

1:00 - 2:20 PM | Plenary Session 3: Thromboinflammatin in CVD
Chairs: Shrey Kohli / Leo Nicolai

• Thromboinflammation and protease activated receptors
  Wolfram Ruf
• Immunothrombosis in myocardial infarction
  Amin Polzin
• Type-1 interferon signaling and metabolism
  Luke O‘Niel

Scientific Session 11: Patient stratification
Chairs: Anne-Sophie Kubasch / Rolf Wachter

• Polygenic risk scores in ischemic heart disease
  Anne Tybjærg-Hansen
• Cluster Analyses in metabolic dysfunction and steatotic liver disease
  Romeo Stefano
• New subtypes of statin-intolerance
  Paulina Stürzebecher